MedPath

Breast cancer risk assessment model for Indian wome

Not Applicable
Conditions
Health Condition 1: null- Breast cancer
Registration Number
CTRI/2018/06/014362
Lead Sponsor
AIIMS Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women with biopsy-proven breast cancer, as cases;

Women >18 years of age not having personnal history of cancer, as controls;

Women willing to participate in the study

Exclusion Criteria

Women who are not willing to participate in the study;

Women having known malignancies other than breast carcinoma;

For control group: woman with personnal history of cancer

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To develop an breast cancer risk assessment model applicable to Indian women, as feasible. <br/ ><br> <br/ ><br>2.To validate the above breast cancer risk assessment model prospectively. <br/ ><br>Timepoint: <br/ ><br>Duration of study: from start of study till data collection and analysis , approximately 3 years. however no follow up shall be done as part of this study
Secondary Outcome Measures
NameTimeMethod
To evaluate the clinical applicability of Gail model 2 (GM2) as a means of estimating 5 year and lifetime risk of breast cancer in Indian woman.Timepoint: Duration of study: from start of study till data collection and analysis , approximately 3 years. however no follow up shall be done as part of this study;To study the clinico-epidemiologic and reproductive risk factors for breast cancer in Indian woman. <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: Duration of study: from start of study till data collection and analysis , approximately 3 years. however no follow up shall be done as part of this study
© Copyright 2025. All Rights Reserved by MedPath